The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCLIN.L Share News (CLIN)

  • There is currently no data for CLIN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON BROKER RATINGS: Deutsche Bank cuts Unilever and Britvic to Hold

Thu, 16th Sep 2021 09:53

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

----------

FTSE 100

----------

EXANE BNP RAISES STANDARD CHARTERED TO 'NEUTRAL' (UNDERPERFORM)

----------

DEUTSCHE BANK CUTS SHELL PRICE TARGET TO 1,871 (1,937) PENCE - 'BUY'

----------

DEUTSCHE BANK RAISES BP PRICE TARGET TO 320 (313) PENCE - 'HOLD'

----------

DEUTSCHE BANK CUTS ANGLO AMERICAN PRICE TARGET TO 3,600 (3,700) PENCE - 'BUY'

----------

DEUTSCHE BANK CUTS ANTOFAGASTA PRICE TARGET TO 1,310 (1,320) PENCE - 'HOLD'

----------

DEUTSCHE BANK CUTS RIO TINTO PRICE TARGET TO 6,000 (6,600) PENCE - 'HOLD'

----------

DEUTSCHE BANK CUTS BHP GROUP PRICE TARGET TO 2,200 (2,400) PENCE - 'HOLD'

----------

DEUTSCHE BANK RAISES GLENCORE PRICE TARGET TO 440 (420) PENCE - 'BUY'

----------

RBC RAISES GLENCORE PRICE TARGET TO 400 (360) PENCE - 'OUTPERFORM'

----------

GOLDMAN RAISES GLENCORE PRICE TARGET TO 430 (390) PENCE - 'BUY'

----------

DEUTSCHE BANK CUTS UNILEVER TO 'HOLD' (BUY) - PRICE TARGET 4,600 (4,800) PENCE

----------

JPMORGAN RAISES JD SPORTS FASHION TARGET TO 1,350 (1,300) PENCE - 'OVERWEIGHT'

----------

FTSE 250

----------

CREDIT SUISSE RAISES REDROW PRICE TARGET TO 745 (640) PENCE - 'OUTPERFORM'

----------

DEUTSCHE BANK RAISES REDROW PRICE TARGET TO 800 (673) PENCE - 'BUY'

----------

BARCLAYS RAISES REDROW PRICE TARGET TO 820 (810) PENCE - 'OVERWEIGHT'

----------

JPMORGAN RAISES REDROW PRICE TARGET TO 850 (790) PENCE - 'OVERWEIGHT'

----------

BARCLAYS RAISES DRAX GROUP PRICE TARGET TO 960 (550) PENCE - 'OVERWEIGHT'

----------

JEFFERIES RAISES VESUVIUS PRICE TARGET TO 760 (685) PENCE - 'BUY'

----------

DEUTSCHE BANK CUTS BRITVIC TO 'HOLD' ('BUY') - TARGET 950 PENCE

----------

BERENBERG RAISES TRUSTPILOT PRICE TARGET TO 440 (430) PENCE - 'BUY'

----------

OTHER MAIN MARKET AND AIM

----------

CITIGROUP RAISES SOUTH32 PRICE TARGET TO 200 (185) PENCE - 'BUY'

----------

DEUTSCHE BANK RAISES SOUTH32 PRICE TARGET TO 195 (165) PENCE - 'HOLD'

----------

BERENBERG CUTS PAN AFRICAN RESOURCES PRICE TARGET TO 25 (29) PENCE - 'BUY'

----------

RBC CUTS CLINIGEN PRICE TARGET TO 860 (935) PENCE - 'OUTPERFORM'

----------

BARCLAYS RAISES KEYWORDS STUDIOS TARGET TO 3,550 (3,200) PENCE - 'OVERWEIGHT'

----------

JEFFERIES RAISES KEYWORDS STUDIOS PRICE TARGET TO 3,700 (3,450) PENCE - 'BUY'

----------

BARCLAYS CUTS FEVERTREE DRINKS PRICE TARGET TO 2,400 (2,500) PENCE - 'OVERWEIGHT'

----------

JEFFERIES RAISES FEVERTREE DRINKS PRICE TARGET TO 2,200 (2,100) PENCE - 'HOLD'

----------

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
1 Apr 2022 20:22

IN BRIEF: UK court sanctions Titon takeover of Clinigen

Clinigen Group PLC - Burton On Trent, Staffordshire-based pharmaceutical services - Says Thursday that its takeover by Triton Investment Management Ltd has been sanctioned by the High Court of Justice in England and Wales. Shares will be cancelled from trading on AIM on Tuesday.

Read more
23 Feb 2022 19:06

TRADING UPDATES: IPF swings to profit; Seraphine lowers outlook

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

Read more
23 Feb 2022 13:28

Clinigen revenue rises as shareholders approve its acquisition

(Sharecast News) - Pharmaceuticals and service company Clinigen Group reported a 10% improvement in net revenue from continuing operations in its half-year results on Wednesday, or 14% on an organic basis, to £238.1m.

Read more
16 Feb 2022 10:09

IN BRIEF: Clinigen expects acquisition by Triton to complete in April

Clinigen Group PLC - Burton On Trent, Staffordshire-based pharmaceutical services - Says its acquisition by funds managed by Triton Investment Management Ltd is likely to complete in early April, with its shares due to be cancelled on AIM on April 5. The deal and timeline are subject to antitrust and foreign investment approvals. Triton, a private equity firm submitted a cash offer of 925 pence per share, valuing Clinigen at GBP1.3 billion, which was approved by shareholders last Tuesday. The latest date for completion is September 8.

Read more
9 Feb 2022 10:38

IN BRIEF: Clinigen signs global distribution deal for Qinlock

IN BRIEF: Clinigen signs global distribution deal for Qinlock

Read more
8 Feb 2022 14:41

IN BRIEF: Clinigen shareholders approve takeover by Triton funds

IN BRIEF: Clinigen shareholders approve takeover by Triton funds

Read more
17 Jan 2022 10:05

Triton increases takeover bid for Clinigen to GBP1.3 billion

Triton increases takeover bid for Clinigen to GBP1.3 billion

Read more
17 Jan 2022 07:29

Triton makes 'increased and final' 925p bid for Clinigen

(Sharecast News) - Clinigen announced an increased and final all-cash offer from Triton of 925p per share on Monday.

Read more
12 Jan 2022 11:49

Clinigen reiterates guidance after 'solid' first half

(Sharecast News) - Pharmaceutical products and services company Clinigen reiterated its guidance for EBITDA growth in the 2022 financial year of between 5% and 10% in a trading update on Wednesday.

Read more
12 Jan 2022 11:13

Clinigen holds earnings growth guidance after solid first half

Clinigen holds earnings growth guidance after solid first half

Read more
11 Jan 2022 14:59

CORRECT: UK shareholder meetings calendar - next 7 days

CORRECT: UK shareholder meetings calendar - next 7 days

Read more
11 Jan 2022 14:46

UK shareholder meetings calendar - next 7 days

UK shareholder meetings calendar - next 7 days

Read more
29 Dec 2021 15:55

UK dividends calendar - next 7 days

UK dividends calendar - next 7 days

Read more
8 Dec 2021 11:56

Drugmaker Clinigen agrees to Triton's GBP1.2 billion takeover bid

Drugmaker Clinigen agrees to Triton's GBP1.2 billion takeover bid

Read more
8 Dec 2021 11:45

AIM WINNERS & LOSERS: Rockhopper rises as Navitas enters project

AIM WINNERS & LOSERS: Rockhopper rises as Navitas enters project

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.